- Home
- GRX vs NBTX Comparison
GRX vs NBTX Comparison
Compare GRX & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRX
- NBTX
- Stock Information
- Founded
- GRX 2007
- NBTX 2003
- Country
- GRX United States
- NBTX France
- Employees
- GRX N/A
- NBTX N/A
- Industry
- GRX Finance/Investors Services
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- GRX Finance
- NBTX Health Care
- Exchange
- GRX Nasdaq
- NBTX Nasdaq
- Market Cap
- GRX 149.2M
- NBTX 178.7M
- IPO Year
- GRX N/A
- NBTX 2020
- Fundamental
- Price
- GRX N/A
- NBTX $3.29
- Analyst Decision
- GRX
- NBTX Strong Buy
- Analyst Count
- GRX 0
- NBTX 1
- Target Price
- GRX N/A
- NBTX $8.00
- AVG Volume (30 Days)
- GRX 39.7K
- NBTX 11.4K
- Earning Date
- GRX 01-01-0001
- NBTX 04-02-2025
- Dividend Yield
- GRX 5.98%
- NBTX N/A
- EPS Growth
- GRX N/A
- NBTX N/A
- EPS
- GRX 0.26
- NBTX N/A
- Revenue
- GRX N/A
- NBTX N/A
- Revenue This Year
- GRX N/A
- NBTX N/A
- Revenue Next Year
- GRX N/A
- NBTX $277.81
- P/E Ratio
- GRX $38.50
- NBTX N/A
- Revenue Growth
- GRX N/A
- NBTX N/A
- 52 Week Low
- GRX $7.73
- NBTX $2.76
- 52 Week High
- GRX $10.40
- NBTX $7.51
- Technical
- Relative Strength Index (RSI)
- GRX 39.96
- NBTX 46.34
- Support Level
- GRX $9.36
- NBTX $3.28
- Resistance Level
- GRX $9.59
- NBTX $3.53
- Average True Range (ATR)
- GRX 0.29
- NBTX 0.18
- MACD
- GRX -0.02
- NBTX 0.00
- Stochastic Oscillator
- GRX 35.24
- NBTX 46.48
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.